Browse by Audience
MEMBER

Update Your Profile
Member Spotlights
Refer a Member: IASP Champions
Join a Special Interest Group (SIG)
Find a Chapter
Join Now

RESEARCHER

PAIN
PAIN Reports
Pain Research Forum
Papers of the Week
Webinars and Podcasts
Events

HEALTH CARE PROVIDER

Online Learning - PERC
Webinars & Podcasts
Curricula
Graduate Opportunities
Events

PATIENT & CAREGIVER

RELIEF News
Resources for Living with Pain
Global Alliance of Partners in Pain Advocacy (GAPPA)
Events

PARTNER

Support IASP
Sponsor an Event
Become a Partner

gy2022-1-3
I am a
IASP Logo
Home I AM A Search Login

Papers of the Week

Home / Publications / Pain Research Forum / Papers of the Week / Australian vaccine preventable disease epidemiological review series: varicella-zoster virus infections, 1998-2015.

< BACK TO ARCHIVE


2018


Commun Dis Intell (2018)


http://www.ncbi.nlm.nih.gov/pubmed/30626299?dopt=Abstract


42

Australian vaccine preventable disease epidemiological review series: varicella-zoster virus infections, 1998-2015.

Authors

Australian vaccine preventable disease epidemiological review series: varicella-zoster virus infections, 1998-2015.
Sheel M, Beard F, Quinn H, Dey A, Kirk M, Koehler A, Markey P, McIntyre P, Macartney K
Commun Dis Intell (2018). 2018; 42.
PMID: 30626299.

Abstract

In 2005, the National Immunisation Program implemented a varicella vaccine for children aged 18 months, and in 2016, a herpes zoster (HZ) vaccine for adults aged 70-79 years. This epidemiological review analyses national trends in varicella and HZ for the years 1998-2015 to examine the impact of a funded varicella vaccine and provide a baseline for monitoring the impact of a funded HZ vaccine.